---
title: General_overview_of_H.Pylori_resistance
layout: default
---

# General Overview of H. pylori Resistance

| Dialogue Prompt | References | Generated Output | Expected Output |
|----------------|------------|------------------|-----------------|
| "Given the project file; Clinical Laboratory Analysis - 2023 - Lin - Antibiotic resistance in Helicobacter pylori From potential biomolecular-1.pdf, I'd like you to get the analysis on hpylori resistance by country available and if possible do the mean mode median for those figures" | Yifan_Lin-Yongfu_Shao<br>https://onlinelibrary.wiley.com/doi/10.1002/jcla.24885 | **Amoxicillin Resistance:**<br>- Africa (overall): 72.6%<br>- Algeria: 0%<br>- Cameroon: 100%<br>- China: 2.8%<br>- Vietnam: 25.7%<br>- Europe (overall): 0.4%<br>- Spain: 0%<br>- Italy: 1.0%<br>*Insufficient data for mean, mode, median*<br><br>**Clarithromycin Resistance:**<br>- Africa (overall): 29.2%<br>- Americas (overall): 10%<br>- Eastern Mediterranean (overall): 33%<br>- Europe (overall): 18%<br>- Southeast Asia (overall): 10%<br>- Western Pacific (overall): 34%<br>Mean: 22.37%<br>Median: 23.5%<br>Mode: 10%<br><br>**Levofloxacin Resistance:**<br>[Additional data continues...]<br><br>**Metronidazole Resistance:**<br>[Additional data continues...]<br><br>**Tetracycline Resistance:**<br>[Additional data continues...] | |

